CompletedNCT03204656SBIUpdated Jul 2, 2017

Selective Bronchial Intubation (SBI)

An observational study in Selective Bronchial Tube, sponsored by Centre Chirurgical Marie Lannelongue. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-07-02.

Sponsored by Centre Chirurgical Marie Lannelongue · Observational

Study type: Observational
Model: Other
Time perspective: Prospective
Enrollment: 200
Ages: 18 Years and older
Sex: All

Study summary

Difficult orotracheal intubation carries a risk of hemodynamic collapse, neurological sequelae secondary to cerebral anoxia or death. Anesthetic scores and predictive indices are used to predict difficulties and avoid complications for usual tracheal intubation. However, existing indices are not adapted to selective bronchial intubations.

The aim of the study is to determine the incidence of unexpected difficult SBI using conventional screening tests. It is a prospective descriptive epidemiological monocentric study comparing two groups of patients (selective vs. non selective intubations).

Conditions studied

Selective Bronchial Tube

Keywords

difficult orotracheal intubation
selective lung intubation
unexpected difficult selective lung intubation

In context

Lead sponsor

Centre Chirurgical Marie Lannelongue is the lead sponsor of 40 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

All adult patients with intubation during surgery in Marie Lannelongue's hospital

Inclusion criteria

For adult patients : age greater than or equal to 18 years
Patients with thoracic, cardiac, vascular or plastic surgery

Exclusion criteria

Exclusion Criteria:

Intubations performed before admission to the operating room or catheterization room;
Patient whose age is less than 18 years
Traditional re-intubation at the end of the procedure after a selective lung IOT;
Selective re-intubation in a patient previously intubated on arrival at the operating theater;
IOT in other departments of the HML (intensive care, Pulmonary Postoperative Unit (UPOP), bronchoscopy, hospitalization services, Intensive Care Unit (ICU), etc.).

Study design

Observational model: Other
Time perspective: Prospective
Enrollment: 200 participants (actual)
Patient registry: No

What researchers measure

Primary outcomes

Rate of difficult selective bronchial intubation
Rate (percentage)
Time frame: 1 day

Secondary outcomes

Predictive factors of difficult selective bronchial intubation
questionnaire
Time frame: 1 day

Study locations

1 site

Hôpital Marie Lannelongue
Le Plessis Robinson, 92350, France

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jul 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03204656
Lead sponsor: Centre Chirurgical Marie Lannelongue
Responsible party: Sponsor
First posted: Jul 2, 2017
Start date: Feb 20, 2017
Primary completion: May 20, 2017
Completion: May 20, 2017
Last update: Jul 2, 2017

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Centre Chirurgical Marie Lannelongue

Start the discussion